vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.

Sprout Social, Inc. is the larger business by last-quarter revenue ($120.9M vs $93.1M, roughly 1.3× HIVE Digital Technologies Ltd.). On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 12.9%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 11.8%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.

HIVE vs SPT — Head-to-Head

Bigger by revenue
SPT
SPT
1.3× larger
SPT
$120.9M
$93.1M
HIVE
Growing faster (revenue YoY)
HIVE
HIVE
+205.7% gap
HIVE
218.6%
12.9%
SPT
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
11.8%
SPT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
SPT
SPT
Revenue
$93.1M
$120.9M
Net Profit
$-91.3M
Gross Margin
-27.1%
77.6%
Operating Margin
-9.0%
Net Margin
-98.1%
Revenue YoY
218.6%
12.9%
Net Profit YoY
-234.0%
EPS (diluted)
$-0.38
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
SPT
SPT
Q4 25
$93.1M
$120.9M
Q3 25
$87.3M
$115.6M
Q2 25
$45.6M
$111.8M
Q1 25
$109.3M
Q4 24
$29.2M
$107.1M
Q3 24
$22.6M
$102.6M
Q2 24
$32.2M
$99.4M
Q1 24
$96.8M
Net Profit
HIVE
HIVE
SPT
SPT
Q4 25
$-91.3M
Q3 25
$-15.8M
$-9.4M
Q2 25
$35.0M
$-12.0M
Q1 25
$-11.2M
Q4 24
$68.2M
Q3 24
$80.0K
$-17.1M
Q2 24
$-18.3M
$-16.9M
Q1 24
$-13.6M
Gross Margin
HIVE
HIVE
SPT
SPT
Q4 25
-27.1%
77.6%
Q3 25
4.7%
77.7%
Q2 25
-13.6%
77.7%
Q1 25
77.3%
Q4 24
-43.7%
78.1%
Q3 24
-66.1%
77.4%
Q2 24
-7.4%
77.5%
Q1 24
76.8%
Operating Margin
HIVE
HIVE
SPT
SPT
Q4 25
-9.0%
Q3 25
-7.9%
Q2 25
-11.0%
Q1 25
-10.2%
Q4 24
-12.8%
Q3 24
-16.4%
Q2 24
-16.6%
Q1 24
-13.7%
Net Margin
HIVE
HIVE
SPT
SPT
Q4 25
-98.1%
Q3 25
-18.1%
-8.1%
Q2 25
76.8%
-10.7%
Q1 25
-10.3%
Q4 24
233.2%
Q3 24
0.4%
-16.6%
Q2 24
-56.7%
-17.0%
Q1 24
-14.0%
EPS (diluted)
HIVE
HIVE
SPT
SPT
Q4 25
$-0.38
$-0.18
Q3 25
$-0.07
$-0.16
Q2 25
$0.18
$-0.21
Q1 25
$-0.19
Q4 24
$0.52
$-0.25
Q3 24
$0.00
$-0.30
Q2 24
$-0.17
$-0.30
Q1 24
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
SPT
SPT
Cash + ST InvestmentsLiquidity on hand
$95.3M
Total DebtLower is stronger
$40.0M
Stockholders' EquityBook value
$559.3M
$203.4M
Total Assets
$624.0M
$523.1M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
SPT
SPT
Q4 25
$95.3M
Q3 25
$90.6M
Q2 25
$101.5M
Q1 25
$100.9M
Q4 24
$40.5M
$86.4M
Q3 24
$31.7M
$82.9M
Q2 24
$80.9M
Q1 24
$69.2M
Total Debt
HIVE
HIVE
SPT
SPT
Q4 25
$40.0M
Q3 25
Q2 25
Q1 25
Q4 24
$25.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
HIVE
HIVE
SPT
SPT
Q4 25
$559.3M
$203.4M
Q3 25
$624.6M
$194.1M
Q2 25
$560.5M
$184.6M
Q1 25
$175.3M
Q4 24
$430.9M
$166.6M
Q3 24
$275.5M
$158.1M
Q2 24
$268.6M
$152.1M
Q1 24
$147.3M
Total Assets
HIVE
HIVE
SPT
SPT
Q4 25
$624.0M
$523.1M
Q3 25
$693.0M
$481.4M
Q2 25
$628.7M
$422.9M
Q1 25
$424.7M
Q4 24
$478.6M
$428.3M
Q3 24
$334.7M
$388.8M
Q2 24
$393.6M
Q1 24
$389.9M
Debt / Equity
HIVE
HIVE
SPT
SPT
Q4 25
0.20×
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
SPT
SPT
Operating Cash FlowLast quarter
$46.0M
$10.9M
Free Cash FlowOCF − Capex
$9.9M
FCF MarginFCF / Revenue
8.2%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$39.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
SPT
SPT
Q4 25
$46.0M
$10.9M
Q3 25
$-10.6M
$9.3M
Q2 25
$10.2M
$5.1M
Q1 25
$18.1M
Q4 24
$-28.5M
$4.1M
Q3 24
$-2.2M
$9.0M
Q2 24
$-4.4M
$2.1M
Q1 24
$11.2M
Free Cash Flow
HIVE
HIVE
SPT
SPT
Q4 25
$9.9M
Q3 25
$8.5M
Q2 25
$4.2M
Q1 25
$16.7M
Q4 24
$-55.5M
$3.3M
Q3 24
$-34.7M
$8.5M
Q2 24
$1.6M
Q1 24
$10.1M
FCF Margin
HIVE
HIVE
SPT
SPT
Q4 25
8.2%
Q3 25
7.4%
Q2 25
3.7%
Q1 25
15.3%
Q4 24
-189.9%
3.0%
Q3 24
-153.4%
8.3%
Q2 24
1.6%
Q1 24
10.4%
Capex Intensity
HIVE
HIVE
SPT
SPT
Q4 25
0.9%
Q3 25
0.7%
Q2 25
0.8%
Q1 25
1.2%
Q4 24
92.5%
0.8%
Q3 24
143.9%
0.5%
Q2 24
0.5%
Q1 24
1.1%
Cash Conversion
HIVE
HIVE
SPT
SPT
Q4 25
Q3 25
Q2 25
0.29×
Q1 25
Q4 24
-0.42×
Q3 24
-26.94×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons